Pfizer CEO Says He ‘Wouldn't Worry Much' About Monkeypox; Cuts Drug Prices for Low-Income Countries

Indonesia Berita Berita

Pfizer CEO Says He ‘Wouldn't Worry Much' About Monkeypox; Cuts Drug Prices for Low-Income Countries
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 nbcchicago
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

Pfizer’s CEO said Wednesday that he “wouldn’t worry much” about a recent monkeypox outbreak that has seen cases surge in non-endemic countries.

World's poorest countries to receive medicines at cost

Also included in the list are the company's Covid-19 treatment Paxlovid and breast cancer drug Ibrance, as well as pneumonia vaccine Prevnar 13, rheumatoid arthritis drug Xeljanz and cancer treatments Xalkori and Inlyta.Xinhua News Agency | Xinhua News Agency | Getty Images Through the program, Pfizer said it aims to improve the ease and speed of access to vital medicines for poorer nations.

"Today we are going to achieve that," he said, adding that shareholders"should think that we are doing the right thing."According to the Bill & Melinda Gates Foundation, it can typically take four to seven years longer for new treatments to become available in low-income countries than in advanced economies — if they become available at all.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

nbcchicago /  🏆 545. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pfizer says 3 COVID shots protect children under 5Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
Baca lebih lajut »

Pfizer says 3 COVID shots protect children under 5Pfizer says 3 COVID shots protect children under 5Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week.
Baca lebih lajut »

Pfizer says 3 COVID shots protect children under 5Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced this morning.
Baca lebih lajut »

Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune response, with a safety profile that was similar to placebo, the companies said:
Baca lebih lajut »

3 doses of COVID vaccine are effective for kids under 5, Pfizer says3 doses of COVID vaccine are effective for kids under 5, Pfizer saysThe long-awaited findings bring the vaccine one step closer to a reality for parents of children ages 6 months to 4 years — the only group that remains ineligible for vaccination.
Baca lebih lajut »

Pfizer says 3 COVID shots protect children under 5Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in…
Baca lebih lajut »



Render Time: 2025-03-01 18:44:19